
10,000+ employees
Founded 1897
đ§Ź Biotechnology
đ Pharmaceuticals
đ Manufacturing
đ° $444.8M Post-IPO Debt - Lonza on 2023-11
Biotechnology âą Pharmaceuticals âą Manufacturing
Lonza is a Swiss-based, global contract development and manufacturing organization (CDMO) and life sciences company. It provides integrated end-to-end offerings across biologics and small-molecule drug development and manufacturing â including cell line development, process and analytical development, formulation and primary packaging, drug substance and drug product manufacturing, and regulatory/CMC support. Lonza's capabilities span advanced synthesis and APIs (including HPAPIs), bioconjugation and ADCs, specialized modalities such as cell & gene therapies, mRNA/LNP, microbial processes, and capsule and health-ingredient products. Founded in Switzerland in 1897, Lonza describes itself as a pioneer and world leader in the CDMO industry and operates with ~20,000 colleagues across five continents to support pharmaceutical and biotech customers.
đ„ 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

10,000+ employees
Founded 1897
đ§Ź Biotechnology
đ Pharmaceuticals
đ Manufacturing
đ° $444.8M Post-IPO Debt - Lonza on 2023-11
Biotechnology âą Pharmaceuticals âą Manufacturing
Lonza is a Swiss-based, global contract development and manufacturing organization (CDMO) and life sciences company. It provides integrated end-to-end offerings across biologics and small-molecule drug development and manufacturing â including cell line development, process and analytical development, formulation and primary packaging, drug substance and drug product manufacturing, and regulatory/CMC support. Lonza's capabilities span advanced synthesis and APIs (including HPAPIs), bioconjugation and ADCs, specialized modalities such as cell & gene therapies, mRNA/LNP, microbial processes, and capsule and health-ingredient products. Founded in Switzerland in 1897, Lonza describes itself as a pioneer and world leader in the CDMO industry and operates with ~20,000 colleagues across five continents to support pharmaceutical and biotech customers.
âą Develop, implement, and continuously improve biological contamination control strategies addressing viral, bacterial, fungal, mycoplasma, endotoxin, and other adventitious agent risks âą Drive and oversee the global sterility assurance strategy, including risk assessment, mitigation planning, gap closure, and sustainable implementation across manufacturing sites âą Serve as a global subject matter expert and strategic leader for contamination control and aseptic manufacturing practices âą Lead global sterility assurance risk assessments and support sites in responding to contamination events, sterility failures, microbiological excursions, and adverse trends âą Facilitate root cause investigations and implement effective corrective and preventive actions (CAPAs) across the network âą Promote cross-site collaboration, knowledge sharing, and implementation of best practices âą Drive harmonization of sterility assurance standards and contamination control programs across global sites âą Establish and improve procedures governing facility and equipment design, process design, material transfer, environmental monitoring, microbiological testing, maintenance, cleaning, disinfection, and segregation controls âą Champion continuous improvement initiatives that strengthen contamination control, consistency, and inspection readiness âą Act as the global sterility assurance expert for product development, technology transfer, and new product introductions âą Ensure phase-appropriate sterility assurance practices are embedded throughout development and commercial manufacturing programs âą Support network expansion projects and new facility start-ups as required âą Coach and train employees to strengthen understanding of biological risks, contamination control, and aseptic behaviors âą Support regulatory inspections, customer audits, GQC audits, mock pre-approval inspections, due diligence activities, and other compliance initiatives as a sterility assurance SME âą Monitor evolving industry and regulatory expectations and ensure timely implementation across the network
âą Bachelor's, Master's, or higher degree in Microbiology, Pharmaceutical Sciences, Life Sciences, Biotechnology, Engineering, or a related scientific discipline âą Significant leadership experience within sterile pharmaceutical, biotechnology, biologics, cell and gene therapy, or related GMP-regulated environments âą Deep expertise in sterility assurance, contamination control, microbiology, aseptic processing, and quality risk management âą Demonstrated experience supporting complex investigations, contamination events, and regulatory inspections âą Proven success influencing and leading within global, matrixed organizations âą Expert knowledge of sterile manufacturing regulations and industry standards âą Strong understanding of contamination control strategies and microbiological risk assessment âą Excellent communication, coaching, and stakeholder management skills âą Ability to drive global alignment while balancing site-specific operational needs âą Continuous improvement mindset with a passion for scientific excellence and operational effectiveness
âą Purpose-driven organization contributing to therapies that improve and save lives worldwide âą Opportunities to make a meaningful impact on a global scale âą Culture of innovation, collaboration, and continuous learning âą Opportunities for career ownership and meaningful difference
Apply Nowđ„ 40 minutes ago
Director of Innovation advancing technology solutions for Respireâs chronic respiratory homecare services. Leading vendor strategy, healthcare innovation initiatives, and measurable patient and operational improvements.
đ„ 1 hour ago
Director of Statistics leading clinical trial design, analysis, and regulatory communication at Lilly. Shaping innovative statistical methods for life-changing medicines.
đșđž United States â Remote
đ” $166.5k - $338.8k / year
đ° $6.5M Post-IPO Debt - Eli Lilly on 2024-02
â° Full Time
đŽ Lead
đ Director
đ„ 1 hour ago
Director managing utility interconnection, transmission strategy, and stakeholder relationships for STACKâs data center infrastructure projects. Supporting site development, energy planning, budgets, and regulatory initiatives.
đșđž United States â Remote
đ” $209.3k - $234.6k / year
đ° Series E - Stack Overflow on 2020-12
â° Full Time
đŽ Lead
đ Director
đ„ 1 hour ago
Group Director owning retention, expansion, and profitability for Power Digitalâs founder-led client portfolio. Leading Account Directors and AI-native marketing systems across a U.S. remote division.
đ„ 2 hours ago
Managing Director growing VMG Healthâs enterprise strategy advisory business. Advising hospitals, health systems, and physician organizations on growth, transformation, partnerships, and market positioning.